外科理论与实践 ›› 2025, Vol. 30 ›› Issue (05): 400-408.doi: 10.16139/j.1007-9610.2025.05.05
王玥a, 郭军威b,*, 袁航b, 杜磊a, 贾许杨a, 卜乐b(
), 卢列盛(
)
收稿日期:2025-05-18
出版日期:2025-09-25
发布日期:2025-12-09
通讯作者:
卢列盛,E-mail: luliesheng1980@163.com;作者简介:第一联系人:*:共同第一作者。
WANG Yuea, GUO Junweib,*, YUAN Hangb, DU Leia, JIA Xuyanga, BU Leb(
), Lu Liesheng(
)
Received:2025-05-18
Online:2025-09-25
Published:2025-12-09
摘要:
目的: 探讨肥胖病人腹腔镜胃袖状切除术(LSG)后发生急性术后高血压(APH)的高危因素,并建立预测模型。方法: 回顾性收集2021年8月至2023年12月期间在本院代谢外科接受LSG的肥胖病人资料,分析其临床数据和实验室指标。采用Logistic-LASSO回归筛选APH的独立危险因素,并基于此构建列线图预测模型。通过受试者工作特征(ROC)曲线、Bootstrap重采样、校准曲线、Hosmer-Lemeshow(H-L)检验、决策曲线分析(DCA)和临床影响曲线(CIC)评估模型的预测效能和临床适用性。结果: APH发生率为55.90%。体质量指数(BMI)、血小板计数、球蛋白、尿酸、血钠、纤维蛋白原、空腹血糖以及术前基线舒张压等具有潜在的预测价值。其中BMI(OR=1.066, 95%CI: 1.003~1.137, P=0.046)、血小板计数(OR=0.994, 95%CI: 0.998~0.999, P=0.027)、纤维蛋白原(OR=1.943, 95%CI: 1.128~3.479, P=0.02)和术前基线舒张压(OR=0.953, 95%CI: 0.918~0.985, P=0.006)为独立高危因素。列线图模型曲线下面积(AUC)为0.783(95% CI: 0.711~0.855),灵敏度0.817,特异度0.689。Bootstrap重抽样AUC为0.776(95%CI: 0.702~0.849)。H-L检验P>0.05。校准曲线显示模型拟合良好。DCA和CIC均显示模型具有较好的筛查效率。结论: BMI、血小板计数、纤维蛋白原和术前基线舒张压是LSG后发生APH的独立高危因素,构建的列线图模型具有良好的预测效能和临床实用性,有助于早期筛查和预防LSG病人发生APH。
中图分类号:
王玥, 郭军威, 袁航, 杜磊, 贾许杨, 卜乐, 卢列盛. 肥胖病人腹腔镜胃袖状切除术后急性高血压的预测模型构建[J]. 外科理论与实践, 2025, 30(05): 400-408.
WANG Yue, GUO Junwei, YUAN Hang, DU Lei, JIA Xuyang, BU Le, Lu Liesheng. Construction of prediction model for acute hypertension following laparoscopic sleeve gastrectomy in obese patients[J]. Journal of Surgery Concepts & Practice, 2025, 30(05): 400-408.
表 1
LSG-OP发生APH的单因素分析[M (Q1, Q3) / n(%) / $\bar{x} \pm s$]
| Baseline indicator | ALL (n=161) | Non-APH (n=71) | APH (n=90) | Statistic value | P value |
|---|---|---|---|---|---|
| Age(year) | 32(27, 37) | 32(27, 37) | 31(26, 38) | Z=-0.32 | 0.751 |
| Sex | χ²=10.49 | 0.002 | |||
| Male | 110 (68.32) | 58 (81.69) | 52 (57.78) | ||
| Female | 51 (31.68) | 13 (18.31) | 38 (42.22) | ||
| BMI(kg/m2) | 38.50(34.72, 42.92) | 36.73(34.08, 40.72) | 40.09(35.77, 46.70) | Z=-2.97 | 0.003 |
| Hypertension: | χ²=0.21 | 0.768 | |||
| No | 108 (67.08) | 49 (69.01) | 59 (65.56) | ||
| Yes | 53 (32.92) | 22 (30.99) | 31 (34.44) | ||
| Diabetes: | χ²=0.23 | 0.753 | |||
| No | 101 (62.73) | 46 (64.79) | 55 (61.11) | ||
| Yes | 60 (37.27) | 25 (35.21) | 35 (38.89) | ||
| WBC(×109/L) | 7.60(6.55, 8.89) | 7.38(6.42, 8.86) | 7.64(6.86, 9.09) | Z=-1.00 | 0.316 |
| HB(g/L) | 140.00(129.00, 148.00) | 136.00(129.00, 145.00) | 142.00(128.25, 150.00) | Z=-1.68 | 0.093 |
| PLT(×109/L) | 295.14 ± 71.76 | 309.48 ± 62.53 | 283.83 ± 76.74 | t=2.28 | 0.021 |
| preALB(mg/L) | 270.00 (239.00,304.00) | 279.00 (247.00,304.50) | 267.00 (238.00,299.75) | Z=-0.98 | 0.328 |
| ALB(g/L) | 42.47 ± 3.33 | 43.12 ± 3.56 | 41.95 ± 3.06 | t=2.25 | 0.029 |
| GLB(g/L) | 30.60 (28.60,33.10) | 31.30 (29.05,34.40) | 30.20 (28.33,32.18) | Z=-1.74 | 0.082 |
| DBIL(μmol/L) | 3.70 (2.90,4.70) | 3.70 (2.95,4.55) | 3.65 (2.90,5.15) | Z=-0.18 | 0.854 |
| TBIL(μmol/L) | 10.90 (8.20,14.20) | 10.60 (8.05,13.80) | 11.30 (8.35,15.25) | Z=-0.72 | 0.474 |
| ALT(U/L) | 47.30 (24.20,87.80) | 45.30 (24.15,83.30) | 53.35 (24.80,101.43) | Z=-0.54 | 0.588 |
| AST(U/L) | 25.30 (17.40,45.90) | 25.30 (17.05,41.70) | 25.10 (17.42,46.88) | Z=-0.04 | 0.963 |
| ALP(U/L) | 71.70 (58.00,84.80) | 70.70 (56.90,87.30) | 71.80 (59.97,83.45) | Z=-0.06 | 0.950 |
| GGT(U/L) | 39.30 (27.60,63.00) | 39.60 (28.80,63.65) | 39.20 (26.82,62.77) | Z=-0.37 | 0.712 |
| Urea(mmol/L) | 4.40 (3.80,5.40) | 4.40 (3.80,5.35) | 4.35 (3.80,5.40) | Z=-0.22 | 0.827 |
| Scr(μmol/L) | 60.00 (53.00,67.00) | 58.00 (52.00,64.50) | 62.00 (53.25,70.75) | Z=-1.97 | 0.048 |
| UA(μmol/L) | 416.00 (358.00,495.00) | 389.00 (348.00,460.00) | 450.50 (365.25,523.25) | Z=-2.79 | 0.005 |
| TC(mmol/L) | 5.08 ± 0.87 | 5.08 ± 0.85 | 5.08 ± 0.90 | t=-0.01 | 0.996 |
| TG(mmol/L) | 1.46 (1.02,2.15) | 1.47 (1.03,2.14) | 1.45 (1.02,2.15) | Z=-0.29 | 0.772 |
| HDL(mmol/L) | 1.05 (0.96,1.25) | 1.06 (0.98,1.26) | 1.04 (0.93,1.24) | Z=-0.85 | 0.395 |
| LDL(mmol/L) | 3.39 ± 0.85 | 3.41 ± 0.82 | 3.37 ± 0.87 | t=0.33 | 0.741 |
| K(mmol/L) | 4.14 (3.93,4.30) | 4.16 (3.94,4.28) | 4.13 (3.93,4.32) | Z=-0.18 | 0.857 |
| Na(mmol/L) | 142.00 (140.00,143.00) | 141.00 (140.00,143.00) | 142.00 (141.00,143.00) | Z=-2.49 | 0.013 |
| Mb(μg/L) | 26.50 (20.30,35.30) | 24.10 (19.10,30.50) | 28.30 (21.22,40.43) | Z=-2.57 | 0.010 |
| BNP(ng/L) | 10.00 (10.00,10.00) | 10.00 (10.00,10.00) | 10.00 (10.00,10.00) | Z=-0.07 | 0.944 |
| FIB(g/L) | 3.31 (2.77,3.75) | 3.23 (2.67,3.61) | 3.36 (2.80,3.89) | Z=-1.49 | 0.136 |
| HbA1c(%) | 6.12 (5.67,6.65) | 6.01 (5.69,6.58) | 6.19 (5.66,6.77) | Z=-0.39 | 0.692 |
| FPG(mmol/L) | 5.32 (4.74,6.24) | 5.26 (4.78,6.06) | 5.37 (4.70,6.50) | Z=-0.25 | 0.805 |
| CRP(mg/L) | 6.28 (3.34,11.10) | 5.54 (3.30,9.78) | 6.58 (3.36,11.50) | Z=-1.10 | 0.270 |
| preSBP(mmHg) | 133.03 ± 14.46 | 134.31 ± 12.18 | 132.02 ± 16.03 | t=1.03 | 0.305 |
| preDBP(mmHg) | 83.87 ± 11.60 | 85.96 ± 8.58 | 82.22 ± 13.33 | t=2.15 | 0.033 |
| MAP(mmHg) | 101.00 (93.00,108.33) | 102.67 (96.83,107.33) | 99.83 (91.42,108.67) | Z=-1.47 | 0.140 |
| Surgical time(min) | 1.72 (1.50,2.08) | 1.73 (1.49,2.04) | 1.69 (1.50,2.15) | Z=-0.18 | 0.859 |
表 2
LSG-OP发生APH的多因素分析
| Characteristics | OR | 95% CI | P value |
|---|---|---|---|
| BMI (kg/m2) | 1.066 | (1.003-1.137) | 0.046 |
| PLT (109/L) | 0.994 | (0.988-0.999) | 0.027 |
| GLB (g/L) | 0.908 | (0.810-1.009) | 0.082 |
| UA (μmol/L) | 1.003 | (0.999-1.006) | 0.094 |
| Na (mmol/L) | 1.178 | (0.985-1.420) | 0.077 |
| FIB (g/L) | 1.943 | (1.128-3.479) | 0.020 |
| FPG (mmol/L) | 1.128 | (0.965-1.337) | 0.141 |
| preDBP (mmHg) | 0.953 | (0.918-0.985) | 0.006 |
| [1] |
JEBEILE H, KELLY A S, O'MALLEY G, et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management[J]. Lancet Diabetes Endocrinol, 2022, 10(5):351-365.
doi: 10.1016/S2213-8587(22)00047-X URL |
| [2] |
WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(7):446-461.
doi: 10.1016/S2213-8587(21)00118-2 URL |
| [3] | 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 刘金钢, 等. 中国肥胖及代谢疾病外科治疗指南(2024版)[J]. 中国实用外科杂志, 2024, 44(8):841-849. |
| Thyroid and Metabolic Surgery Group, Chinese Society of Surgery, Chinese Medical Association, Bariatric and Metabolic Surgery Expert Committee, Surgeon Branch of Chinese Medical Doctor Association, LIU J G, et al. Chinese guidelines for surgical treatment of obesity and metabolic diseases (2024 edition)[J]. Chin J Pract Surg, 2024, 44(8):841-849. | |
| [4] | 邢颖, 闫文貌, 白日星. 腹腔镜下胃袖状切除术在超级肥胖患者中减重效果及安全性分析[J]. 中国普通外科杂志, 2022, 31(10):1307-1315. |
| XING Y, YAN W M, BAI R X. Analysis of the efficacy and safety of laparoscopic sleeve gastrectomy in patients with super obesity[J]. Chin J Gen Surg, 2022, 31(10):1307-1315. | |
| [5] |
ZHOU Y, LUO D, SHAO L, et al. Risk factors for acute postoperative hypertension in non-cardiac major surgery: a case control study[J]. BMC Anesthesiol, 2023, 23(1):167.
doi: 10.1186/s12871-023-02121-0 pmid: 37193947 |
| [6] |
MARIK P E, VARON J. Perioperative hypertension: a review of current and emerging therapeutic agents[J]. J Clin Anesth, 2009, 21(3):220-229.
doi: 10.1016/j.jclinane.2008.09.003 pmid: 19464619 |
| [7] |
LOU N, WANG D, WANG Z, et al. Management of acute postoperative hypertension for reducing cardiovascular complications in cancer patients: when and how aggressively?[J]. Turk J Med Sci, 2016, 46(6):1634-1640.
doi: 10.3906/sag-1412-33 pmid: 28081339 |
| [8] | TAN J, WANG Q, SHI W, et al. A machine learning approach for predicting early phase postoperative hypertension in patients undergoing carotid endarterectomy[J]. Ann Vasc Surg, 2021,71:121-131. |
| [9] |
BORRONI R G, CARUGNO A, RIVETTI N, et al. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer[J]. Photodermatol Photoimmunol Photomed, 2013, 29(2):73-77.
doi: 10.1111/phpp.2013.29.issue-2 URL |
| [10] |
SCHIAVON C A, CAVALCANTI A B, OLIVEIRA J D, et al. Randomized trial of effect of bariatric surgery on blood pressure after 5 years[J]. J Am Coll Cardiol, 2024, 83(6):637-648.
doi: 10.1016/j.jacc.2023.11.032 pmid: 38325988 |
| [11] |
NELSON B. CytoSource: current issues for cytopathology[J]. Cancer Cytopathol, 2015, 123(5):267-268.
doi: 10.1002/cncy.21556 pmid: 25970843 |
| [12] |
LASSE M, PILBROW A P, KLEFFMANN T, et al. Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals[J]. Sci Rep, 2021, 11(1):4605.
doi: 10.1038/s41598-021-84046-7 pmid: 33633217 |
| [13] |
ZABCZYK M, ARIENS R A S, UNDAS A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice[J]. Cardiovasc Res, 2023, 119(1):94-111.
doi: 10.1093/cvr/cvad017 pmid: 36662542 |
| [14] | 杨利娟. 血浆纤维蛋白原水平与高血压患者代谢异常的关系[D]. 福建: 福建医科大学, 2016. |
| YANG L J. Association between plasma fibrinogen levels and metabolic abnormalities in patients with hypertension[D]. Fujian: Fujian Medical University, 2016. | |
| [15] |
WALCO J P, RENGEL K F, MCEVOY M D, et al. Association between preoperative blood pressures and post-operative adverse events[J]. Anesthesiology, 2024, 141(2):272-285.
doi: 10.1097/ALN.0000000000004991 URL |
| [1] | 苑辰, 朱珊, 李臻臻, 等.
瘢痕疙瘩术后浅层X线放疗的不良反应及相关危险因素分析
[J]. 组织工程与重建外科杂志, 2025, 21(5): 467-. |
| [2] | 赖柏翰, 魏伯轩, 金佳敏, 等. 中国先天性巨大黑痣的流行病学以及危险因素调查研究[J]. 组织工程与重建外科杂志, 2025, 21(3): 250-. |
| [3] | 秦文英, 韩文娟, 桂芫芫. 小耳畸形外耳再造术后并发症相关危险因素预测模型建立及结构式与叙事疗法分析[J]. 组织工程与重建外科杂志, 2025, 21(3): 258-. |
| [4] | 唐春花, 郭露, 张莉莉. 2025年全球卒中报告数据解读:卒中疾病负担的梯度演变与精准治理[J]. 诊断学理论与实践, 2025, 24(05): 485-497. |
| [5] | 杨梅, 廖啟安, 谭全会, 李婷婷, 张毅, 陈洁, 汤正好. 医院获得性细菌性脑膜炎患者预后不良的危险因素分析及列线图预测模型的构建[J]. 诊断学理论与实践, 2025, 24(04): 441-448. |
| [6] | 徐婷, 戎捷骊, 顾仁丽, 徐阳, 刘小江. 老年脑卒中患者预后不良危险因素筛选及其相互作用探索[J]. 内科理论与实践, 2025, 20(04): 296-300. |
| [7] | 杨启瑞, 白婷婷, 蒋倩雯, 张伟奇, 鲁怡音, 赵伟, 吴方, 李菲卡. 老年射血分数保留型心力衰竭患者合并肌少症预后因素分析[J]. 内科理论与实践, 2025, 20(03): 210-215. |
| [8] | 董文培, 杨建军, 顾岩. 单孔减重手术:优势与存在的问题[J]. 外科理论与实践, 2025, 30(03): 202-206. |
| [9] | 张男男, 郭金星, 吴钢, 易辉, 周远航, 廖芝伟, 黄琦, 董建. 腹腔镜胆囊切除术中转开腹评估体系的建立及手术分级管理探索[J]. 外科理论与实践, 2025, 30(01): 54-60. |
| [10] | 雷朝闻尉, 饶佳玲, 周梦雪, 杨虹. 胰腺脂肪沉积的危险因素及相关疾病的研究进展[J]. 诊断学理论与实践, 2025, 24(01): 72-79. |
| [11] | 宋春林, 罗成军, 朱雨. 四肢创伤性软组织缺损患者游离皮瓣移植失败的危险因素及预测模型构建 [J]. 组织工程与重建外科杂志, 2024, 20(3): 305-. |
| [12] | 续慧民, 高红霞. 髂股静脉术后支架内再狭窄因素的分析及处理[J]. 外科理论与实践, 2024, 29(06): 481-486. |
| [13] | 吴昕菀, 李响, 郑旻嘉, 姚俊岩. 影响老年病人全身麻醉非心脏手术术后谵妄发生的因素[J]. 外科理论与实践, 2024, 29(06): 510-517. |
| [14] | 龚婷婷, 钱爱华, 陈希. 个体化预测早期胃癌内镜黏膜下剥离术后迟发性出血风险的列线图模型构建[J]. 外科理论与实践, 2024, 29(03): 236-242. |
| [15] | 林起柱, 刘红枝, 黄霆峰, 范瑞林, 周伟平, 郑树国, 楼健颖, 曾永毅. 基于肝内胆管癌预后模型筛选辅助化疗受益人群[J]. 外科理论与实践, 2024, 29(02): 170-178. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||